First Header Logo Second Header Logo

Robert Hurley

Concepts (303)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Low Back Pain
12
2020
45
2.960
Why?
Analgesics, Opioid
14
2022
232
1.910
Why?
Pain, Postoperative
10
2019
178
1.810
Why?
Autonomic Nerve Block
3
2015
10
1.460
Why?
Pain Measurement
18
2020
350
1.240
Why?
Analgesics
9
2018
109
1.110
Why?
Primary Health Care
7
2024
227
1.080
Why?
Perioperative Care
3
2019
59
1.060
Why?
Sacroiliac Joint
3
2014
12
0.970
Why?
Midazolam
2
2014
10
0.960
Why?
Diagnostic Techniques and Procedures
2
2014
7
0.950
Why?
Conscious Sedation
2
2014
24
0.950
Why?
Anesthetics, Intravenous
2
2014
17
0.950
Why?
Electronic Health Records
4
2024
162
0.950
Why?
Fentanyl
2
2014
32
0.940
Why?
Complex Regional Pain Syndromes
2
2014
19
0.940
Why?
Patient Satisfaction
2
2016
240
0.890
Why?
Pain
7
2012
288
0.870
Why?
Obesity
5
2014
1175
0.850
Why?
gamma-Aminobutyric Acid
4
2008
75
0.840
Why?
Osteoarthritis, Knee
1
2023
90
0.830
Why?
Humans
59
2024
31974
0.820
Why?
Opioid-Related Disorders
6
2019
55
0.750
Why?
Fear
3
2014
48
0.670
Why?
Buprenorphine
1
2019
13
0.660
Why?
Treatment Outcome
15
2023
3302
0.640
Why?
Zygapophyseal Joint
2
2007
3
0.600
Why?
Decision Support Systems, Clinical
3
2024
59
0.580
Why?
Male
38
2024
19143
0.570
Why?
Anesthetics, Local
3
2015
79
0.560
Why?
Resistance Training
2
2014
82
0.560
Why?
Neuralgia
2
2015
48
0.550
Why?
Cyclohexanecarboxylic Acids
3
2006
21
0.550
Why?
Amines
3
2006
22
0.550
Why?
Denervation
4
2008
13
0.530
Why?
Practice Guidelines as Topic
3
2020
407
0.520
Why?
Stellate Ganglion
1
2015
1
0.510
Why?
Ventricular Fibrillation
1
2015
4
0.510
Why?
Medulla Oblongata
5
2007
51
0.500
Why?
Disability Evaluation
3
2014
240
0.490
Why?
Receptors, Opioid, mu
4
2007
31
0.490
Why?
Phantom Limb
1
2014
4
0.480
Why?
Middle Aged
22
2024
11804
0.480
Why?
Receptors, Opioid, delta
5
2007
12
0.460
Why?
Health Knowledge, Attitudes, Practice
2
2015
353
0.450
Why?
Schools, Medical
1
2014
43
0.450
Why?
Exercise Therapy
2
2014
269
0.440
Why?
Anesthesiology
1
2014
49
0.430
Why?
Faculty, Medical
1
2014
78
0.430
Why?
Diabetic Neuropathies
2
2013
24
0.430
Why?
Spinal Cord
4
2004
130
0.410
Why?
Female
27
2024
19939
0.410
Why?
Delivery of Health Care
1
2014
160
0.400
Why?
Nociceptors
6
2004
41
0.400
Why?
Health Behavior
1
2013
232
0.400
Why?
Osteoarthritis
1
2012
79
0.390
Why?
Postoperative Care
3
2019
76
0.390
Why?
Adult
15
2024
9339
0.370
Why?
Walking
4
2014
209
0.340
Why?
Anemia, Sickle Cell
2
2020
45
0.340
Why?
Catheter Ablation
2
2008
67
0.340
Why?
Randomized Controlled Trials as Topic
4
2017
510
0.330
Why?
Societies, Medical
3
2018
163
0.330
Why?
Pain Threshold
2
2008
92
0.320
Why?
Ketamine
2
2018
19
0.310
Why?
Aged
14
2018
10294
0.310
Why?
Hyperalgesia
4
2007
78
0.310
Why?
Patient Selection
2
2022
276
0.300
Why?
Spinal Diseases
1
2007
16
0.300
Why?
Inflammation
4
2007
530
0.300
Why?
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
3
2007
14
0.300
Why?
Cervical Vertebrae
1
2007
44
0.290
Why?
Risk Factors
9
2019
3867
0.290
Why?
Oligopeptides
4
2007
45
0.280
Why?
Orthopedic Procedures
1
2007
89
0.280
Why?
United States
7
2020
3931
0.280
Why?
Ganglia, Spinal
2
2006
65
0.270
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2007
73
0.270
Why?
Analgesia
2
2016
29
0.260
Why?
Decision Support Techniques
2
2018
128
0.260
Why?
Aged, 80 and over
8
2016
3988
0.260
Why?
Rats, Sprague-Dawley
9
2007
743
0.250
Why?
Physical Endurance
3
2013
35
0.250
Why?
Nerve Block
3
2012
50
0.240
Why?
Enkephalins
2
2001
10
0.230
Why?
Gait
3
2014
141
0.230
Why?
Radiosurgery
1
2007
356
0.230
Why?
Postural Balance
1
2016
181
0.230
Why?
Brain
3
2019
951
0.220
Why?
Pesticides
1
2016
199
0.220
Why?
Efferent Pathways
1
2003
8
0.220
Why?
Rats
9
2007
1595
0.220
Why?
Occupational Exposure
1
2016
232
0.220
Why?
Receptors, Opioid
1
2003
12
0.220
Why?
Naproxen
1
2002
7
0.220
Why?
Injections, Spinal
3
2016
108
0.220
Why?
Acetates
1
2002
10
0.210
Why?
Algorithms
2
2017
492
0.210
Why?
Transients and Migrants
1
2016
290
0.210
Why?
Emigrants and Immigrants
1
2016
244
0.210
Why?
Research Design
2
2017
313
0.210
Why?
Neurons
2
2003
410
0.200
Why?
Consensus
5
2019
85
0.200
Why?
Muscle Strength
2
2013
161
0.200
Why?
Knee Joint
1
2023
142
0.200
Why?
Anesthesia, Conduction
2
2018
25
0.190
Why?
Hematology
1
2020
8
0.180
Why?
Predictive Value of Tests
3
2013
873
0.180
Why?
Animals
12
2010
7541
0.180
Why?
Lower Extremity
1
2020
100
0.170
Why?
Body Mass Index
3
2013
922
0.170
Why?
Periaqueductal Gray
1
2019
2
0.170
Why?
User-Computer Interface
1
2019
51
0.170
Why?
Hispanic Americans
1
2016
940
0.170
Why?
Analgesics, Non-Narcotic
1
2017
13
0.150
Why?
Classification
1
2017
1
0.150
Why?
Analgesia, Epidural
2
2010
50
0.150
Why?
Microinjections
4
2001
35
0.150
Why?
Medical History Taking
1
2017
37
0.140
Why?
Medical Informatics
1
2016
27
0.140
Why?
Cluster Analysis
1
2016
125
0.140
Why?
Lumbar Vertebrae
2
2007
101
0.140
Why?
Ambulatory Care Facilities
1
2016
83
0.140
Why?
Cross-Over Studies
2
2014
95
0.130
Why?
Placebos
1
2015
63
0.130
Why?
Organizational Case Studies
1
2015
11
0.130
Why?
Quality Assurance, Health Care
1
2016
72
0.130
Why?
Neurosurgical Procedures
1
2016
99
0.130
Why?
Evidence-Based Medicine
4
2020
217
0.130
Why?
Electric Countershock
1
2015
11
0.130
Why?
Sympathectomy
1
2015
21
0.130
Why?
Volleyball
1
2015
1
0.130
Why?
Terminology as Topic
3
2019
64
0.130
Why?
Receptors, Opioid, kappa
2
2008
24
0.130
Why?
Family Practice
1
2015
51
0.120
Why?
Drug Synergism
4
2007
66
0.120
Why?
Soccer
1
2015
19
0.120
Why?
Young Adult
3
2019
2635
0.120
Why?
Qualitative Research
3
2020
167
0.120
Why?
Retrospective Studies
5
2015
3502
0.120
Why?
Drug Administration Schedule
3
2019
276
0.120
Why?
Spinal Nerves
1
2015
65
0.120
Why?
Brain Concussion
1
2015
62
0.120
Why?
Overweight
2
2013
279
0.120
Why?
Injections, Intra-Articular
1
2014
16
0.120
Why?
False Positive Reactions
1
2014
29
0.120
Why?
Efficiency
1
2014
18
0.120
Why?
Joints
1
2013
13
0.120
Why?
Baseball
1
2015
41
0.120
Why?
Neuralgia, Postherpetic
1
2013
6
0.110
Why?
Neurotoxicity Syndromes
1
2013
19
0.110
Why?
Patient Acceptance of Health Care
1
2015
171
0.110
Why?
Cost of Illness
1
2013
70
0.110
Why?
Patient Education as Topic
1
2015
271
0.110
Why?
Health Policy
1
2014
82
0.110
Why?
Affect
1
2013
69
0.110
Why?
Phobic Disorders
1
2013
9
0.110
Why?
Chronic Disease
3
2013
405
0.110
Why?
Time Factors
5
2019
2147
0.110
Why?
Health Care Surveys
1
2014
185
0.110
Why?
Peripheral Nervous System Diseases
1
2013
51
0.110
Why?
Patient Care Team
1
2013
129
0.110
Why?
Adaptation, Psychological
1
2013
138
0.110
Why?
Celiac Plexus
1
2012
3
0.100
Why?
Databases, Factual
1
2014
351
0.100
Why?
Risk Assessment
4
2019
1422
0.100
Why?
Combined Modality Therapy
1
2013
560
0.100
Why?
Incidence
3
2019
1196
0.100
Why?
Mobility Limitation
1
2013
219
0.100
Why?
Adolescent
4
2019
3537
0.090
Why?
Pancreatic Neoplasms
1
2012
134
0.090
Why?
Behavior, Addictive
1
2010
32
0.090
Why?
Checklist
1
2010
38
0.090
Why?
Diet
1
2012
391
0.080
Why?
Delphi Technique
2
2019
40
0.080
Why?
Epidural Space
1
2009
8
0.080
Why?
Muscle, Skeletal
1
2013
519
0.080
Why?
Steroids
1
2009
38
0.080
Why?
Regression Analysis
3
2013
293
0.080
Why?
HIV Infections
1
2013
394
0.080
Why?
Infusions, Intravenous
2
2018
100
0.080
Why?
Neck Pain
1
2007
6
0.080
Why?
Magnetic Resonance Imaging
2
2019
1328
0.070
Why?
Radiculopathy
1
2007
5
0.070
Why?
Models, Statistical
1
2008
173
0.070
Why?
Receptors, Tumor Necrosis Factor
1
2007
46
0.070
Why?
Hindlimb
3
2007
54
0.070
Why?
Positron-Emission Tomography
1
2008
163
0.070
Why?
Sex Characteristics
1
2008
173
0.070
Why?
Data Interpretation, Statistical
1
2007
109
0.070
Why?
Forecasting
1
2007
143
0.070
Why?
Immunoglobulin G
1
2007
122
0.070
Why?
Nortriptyline
1
2006
2
0.070
Why?
Carbamazepine
1
2006
5
0.070
Why?
Thoracotomy
1
2006
21
0.070
Why?
Reaction Time
2
2007
117
0.070
Why?
Dose-Response Relationship, Drug
3
2007
632
0.070
Why?
Fluoroscopy
1
2006
40
0.070
Why?
Mastectomy
1
2006
64
0.070
Why?
Anticonvulsants
1
2006
65
0.070
Why?
Adrenergic alpha-Antagonists
2
2003
24
0.070
Why?
Prevalence
1
2008
981
0.060
Why?
Disease Models, Animal
1
2008
1022
0.060
Why?
Surgical Procedures, Operative
1
2004
82
0.060
Why?
Calcium
2
2002
307
0.060
Why?
Case-Control Studies
1
2016
893
0.060
Why?
Receptors, GABA
1
2003
6
0.050
Why?
Serotonin Antagonists
1
2003
5
0.050
Why?
GABA Antagonists
1
2003
12
0.050
Why?
Medicare
1
2004
206
0.050
Why?
Receptors, Serotonin
1
2003
7
0.050
Why?
Narcotics
1
2003
16
0.050
Why?
Drug Interactions
1
2003
78
0.050
Why?
Attitude of Health Personnel
1
2024
183
0.050
Why?
Quality of Life
1
2008
946
0.050
Why?
Research Subjects
1
2022
17
0.050
Why?
Electronics
1
2022
14
0.050
Why?
Calcium Channels
1
2002
57
0.050
Why?
Exercise Test
2
2013
227
0.050
Why?
HIV Envelope Protein gp120
1
2001
4
0.050
Why?
Patient-Centered Care
1
2022
75
0.050
Why?
Benzeneacetamides
1
2001
3
0.050
Why?
Chemokines
1
2001
35
0.050
Why?
Pyrrolidines
1
2001
12
0.050
Why?
North Carolina
1
2016
1514
0.050
Why?
Somatostatin
1
2001
11
0.050
Why?
Naltrexone
1
2001
18
0.050
Why?
Reproducibility of Results
2
2016
762
0.050
Why?
Indiana
1
2020
26
0.050
Why?
Peptides
1
2001
120
0.050
Why?
Skin Temperature
1
2000
16
0.040
Why?
Age Factors
2
2013
1187
0.040
Why?
Receptors, Adrenergic, alpha-2
1
1999
33
0.040
Why?
Enkephalin, D-Penicillamine (2,5)-
1
1999
5
0.040
Why?
Norepinephrine
1
1999
77
0.040
Why?
Rest
1
2019
53
0.040
Why?
Child
2
2020
2436
0.040
Why?
Neural Pathways
1
2019
94
0.040
Why?
Cohort Studies
2
2013
1813
0.040
Why?
Logistic Models
2
2015
778
0.040
Why?
Brain Mapping
1
2019
178
0.040
Why?
Pilot Projects
2
2012
545
0.040
Why?
Peptide Fragments
1
2001
399
0.040
Why?
Nerve Net
1
2019
123
0.040
Why?
Syndrome
1
2017
72
0.040
Why?
Medication Adherence
1
2020
161
0.040
Why?
Quality of Health Care
1
2018
147
0.040
Why?
Public-Private Sector Partnerships
1
2017
4
0.040
Why?
Prospective Studies
2
2016
2278
0.040
Why?
Decision Making
1
2018
195
0.030
Why?
Clinical Protocols
1
2016
98
0.030
Why?
Decision Trees
1
2015
30
0.030
Why?
Random Allocation
1
2015
226
0.030
Why?
ROC Curve
1
2015
162
0.030
Why?
Sports
1
2015
36
0.030
Why?
Clinical Trials as Topic
1
2016
301
0.030
Why?
Cross-Sectional Studies
1
2018
1532
0.030
Why?
Physician-Patient Relations
1
2015
185
0.030
Why?
Self Concept
1
2013
43
0.030
Why?
Follow-Up Studies
2
2008
2265
0.030
Why?
Obesity, Morbid
1
2013
73
0.030
Why?
Activities of Daily Living
1
2013
257
0.020
Why?
African Americans
1
2019
1425
0.020
Why?
Iatrogenic Disease
1
2010
15
0.020
Why?
Drug Evaluation, Preclinical
1
2010
62
0.020
Why?
Severity of Illness Index
1
2013
881
0.020
Why?
Substance-Related Disorders
1
2010
128
0.020
Why?
Injections, Epidural
1
2009
9
0.020
Why?
Lumbosacral Region
1
2009
11
0.020
Why?
Freund's Adjuvant
1
2007
2
0.020
Why?
Guanosine 5'-O-(3-Thiotriphosphate)
1
2007
20
0.020
Why?
Cell Membrane
1
2007
96
0.020
Why?
Weight-Bearing
1
2007
40
0.020
Why?
Medical Records
1
2007
76
0.020
Why?
Radiography
1
2007
376
0.020
Why?
Double-Blind Method
1
2007
525
0.020
Why?
Databases as Topic
1
2004
22
0.020
Why?
Sampling Studies
1
2004
44
0.020
Why?
Pneumonia
1
2004
68
0.010
Why?
Peripheral Nerves
1
2004
62
0.010
Why?
Odds Ratio
1
2004
472
0.010
Why?
Synaptic Transmission
1
2004
117
0.010
Why?
Multivariate Analysis
1
2004
683
0.010
Why?
Prognosis
1
2007
1495
0.010
Why?
Intracellular Fluid
1
2001
3
0.010
Why?
Receptors, CXCR4
1
2001
11
0.010
Why?
Receptors, CCR4
1
2001
3
0.010
Why?
Bradykinin
1
2001
12
0.010
Why?
Receptors, Chemokine
1
2001
9
0.010
Why?
Substance P
1
2001
20
0.010
Why?
Capsaicin
1
2001
24
0.010
Why?
Adenosine Triphosphate
1
2001
53
0.010
Why?
Tail
1
2001
5
0.010
Why?
Fluorescent Dyes
1
2001
48
0.010
Why?
Excitatory Postsynaptic Potentials
1
2001
32
0.010
Why?
Hot Temperature
1
2001
71
0.010
Why?
Neurons, Afferent
1
2001
56
0.010
Why?
Yohimbine
1
1999
4
0.010
Why?
Dexmedetomidine
1
1999
8
0.010
Why?
RNA, Messenger
1
2001
508
0.010
Why?
Anesthesia, Spinal
1
1999
20
0.010
Why?
Adrenergic alpha-Agonists
1
1999
42
0.010
Why?
Cells, Cultured
1
2001
833
0.010
Why?
Hurley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (303)
Explore
_
Co-Authors (10)
Explore
_
Similar People (50)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_